SIGNIFICANCE OF C-MET AS A THERAPEUTIC TARGET IN TRIPLE-NEGATIVE BREAST CANCER

被引：0
|
作者：
Kashiwagi, S. [1 ]
Yashiro, M. [1 ]
Aomatsu, N. [1 ]
Kawajiri, H. [1 ]
Takashima, T. [1 ]
Onoda, N. [1 ]
Ishikawa, T. [1 ]
Hirakawa, K. [1 ]
机构：
[1] Osaka City Univ, Grad Sch Med, Osaka 558, Japan
来源：
ANNALS OF ONCOLOGY | 2012年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：84 / 84
页数：1
相关论文
共 50 条
  • [31] Significance of the vimentin expression in triple-negative breast cancer
    Yamashita, Nami
    Tokunaga, Eriko
    Kitao, Hiroyuki
    Tanaka, Kimihiro
    Taketani, Kenji
    Saeki, Hiroshi
    Aishima, Shinichi
    Oki, Eiji
    Morita, Masaru
    Maehara, Yoshihiko
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [32] Prognostic significance of triple-negative phenotype in breast cancer
    Choi, M. Y.
    Lee, K. E.
    Chang, H. J.
    Sung, S. H.
    Moon, B. I.
    Choi, H. Y.
    Suh, H. S.
    Nam, E. M.
    Mun, Y. C.
    Seong, C. M.
    Lee, S. N.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [33] c-Met and ERβ expression differences in basal-like and non-basal-like triple-negative breast cancer
    Ren, Xinyu
    Yuan, Li
    Shen, Songjie
    Wu, Hanwen
    Lu, Junliang
    Liang, Zhiyong
    TUMOR BIOLOGY, 2016, 37 (08) : 11385 - 11395
  • [34] Prognostic significance of triple-negative phenotype in breast cancer
    Lee, K. E.
    Choi, M. Y.
    Chang, H. J.
    Sung, S. H.
    Moon, B. I.
    Choi, H. Y.
    Nam, E. M.
    Mun, Y. C.
    Seong, C. M.
    Lee, S. N.
    EJC SUPPLEMENTS, 2008, 6 (07): : 188 - 188
  • [35] Significance of Histomorphology of Early Triple-Negative Breast Cancer
    Rubovszky, Gabor
    Horvath, Zsolt
    Toth, Erika
    Lang, Istvan
    Kasler, Miklos
    PATHOLOGY & ONCOLOGY RESEARCH, 2012, 18 (04) : 823 - 831
  • [36] C-Met is a potential therapeutic target for antibody-drug conjugates in breast cancer
    Fu, Yanwen
    Gros, Edwige
    Lee, Alice
    Johnson, Kimberly
    Zhang, Hong
    Yalamanchili, Silpa
    Motamed, Kouros
    Chen, Gary
    Jones, Bryan
    Miao, David
    Kaufmann, Gunnar F.
    CANCER RESEARCH, 2015, 75
  • [37] BRAF: An emerging target for triple-negative breast cancer
    Albanell, Joan
    Elvin, Julia Andrea
    Ali, Siraj Mahamed
    Schrock, Alexa Betzig
    Chung, Jon
    Vergilio, Jo-Anne
    Suh, James
    Ramkissoon, Shakti
    Severson, Eric Allan
    Daniel, Sugganth
    Miller, Vincent A.
    Stephens, Philip J.
    Gay, Laurie M.
    Ross, Jeffrey S.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [38] (+)-Dehydroabietylamine derivatives target triple-negative breast cancer
    Ling, Taotao
    Tran, My
    Gonzalez, Miguel A.
    Gautam, Lekh Nath
    Connelly, Michele
    Wood, Rachael K.
    Fatima, Iram
    Miranda-Carboni, Gustavo
    Rivas, Fatima
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2015, 102 : 9 - 13
  • [39] MET is a potential therapeutic target and a candidate for combination therapy with EGFR inhibition in triple-negative/basal-like breast cancer
    Kim, Yu Jin
    Choi, Jong-Sun
    Song, Ji-Young
    Jung, Kyungsoo
    Oh, Ensel
    Shin, Young Kee
    Choi, Yoon-La
    CANCER RESEARCH, 2013, 73 (08)
  • [40] Targeted Therapeutic Strategies for Triple-Negative Breast Cancer
    Li, Ying
    Zhan, Zhijun
    Yin, Xuemin
    Fu, Shujun
    Deng, Xiyun
    FRONTIERS IN ONCOLOGY, 2021, 11
12345